# A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder

> **NCT00518232** · PHASE4 · COMPLETED · sponsor: **Johnson & Johnson Taiwan Ltd** · enrollment: 520 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** OROS-methylphenidate

## Key facts

- **NCT ID:** NCT00518232
- **Lead sponsor:** Johnson & Johnson Taiwan Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2010-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00518232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00518232, "A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00518232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*